Monopar Therapeutics Statistics
Total Valuation
MNPR has a market cap or net worth of $10.95 million. The enterprise value is $3.69 million.
| Market Cap | 10.95M |
| Enterprise Value | 3.69M |
Important Dates
The next estimated earnings date is Thursday, May 9, 2024, before market open.
| Earnings Date | May 9, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
MNPR has 17.45 million shares outstanding. The number of shares has increased by 8.69% in one year.
| Shares Outstanding | 17.45M |
| Shares Change (YoY) | +8.69% |
| Shares Change (QoQ) | +3.70% |
| Owned by Insiders (%) | 52.35% |
| Owned by Institutions (%) | 1.55% |
| Float | 8.31M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 1.96 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.17, with zero debt.
| Current Ratio | 4.17 |
| Quick Ratio | n/a |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -116.00% and return on invested capital (ROIC) is -158.05%.
| Return on Equity (ROE) | -116.00% |
| Return on Assets (ROA) | -88.20% |
| Return on Capital (ROIC) | -158.05% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$933,577 |
| Employee Count | 9 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -43.47% in the last 52 weeks. The beta is 1.20, so MNPR's price volatility has been higher than the market average.
| Beta (1Y) | 1.20 |
| 52-Week Price Change | -43.47% |
| 50-Day Moving Average | 0.75 |
| 200-Day Moving Average | 0.57 |
| Relative Strength Index (RSI) | 44.20 |
| Average Volume (30 Days) | 5,500,241 |
Short Selling Information
The latest short interest is 150,010, so 0.86% of the outstanding shares have been sold short.
| Short Interest | 150,010 |
| Short Previous Month | 170,498 |
| Short % of Shares Out | 0.86% |
| Short % of Float | 1.80% |
| Short Ratio (days to cover) | 0.60 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -8.83M |
| Pretax Income | -8.40M |
| Net Income | -8.40M |
| EBITDA | -8.40M |
| EBIT | -8.40M |
| Earnings Per Share (EPS) | -$0.61 |
Balance Sheet
The company has $7.27 million in cash and no debt, giving a net cash position of $7.27 million or $0.42 per share.
| Cash & Cash Equivalents | 7.27M |
| Total Debt | n/a |
| Net Cash | 7.27M |
| Net Cash Per Share | $0.42 |
| Equity / Book Value | 5.59M |
| Book Value Per Share | 0.32 |
| Working Capital | 5.58M |
Cash Flow
| Operating Cash Flow | -7.86M |
| Capital Expenditures | n/a |
| Free Cash Flow | -7.86M |
| FCF Per Share | -$0.57 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
MNPR does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -8.69% |
| Shareholder Yield | -8.69% |
| Earnings Yield | -76.71% |
| FCF Yield | -71.75% |
Analyst Forecast
The average price target for MNPR is $9.50, which is 1,413.94% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $9.50 |
| Price Target Difference | 1,413.94% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |